weight loss semaglutide vs tirzepatide vs Retatrutide Comparison | Matthew Cote posted on the topic Semaglutide vs. Tirzepatide: How Weight-Loss

Monitoring and follow-up are essential

In short, on October 2, 2024, FDA announced that Lilly had resolved the tirzepatide shortage, but five days later the Outsourcing Facilities Association ( OFA ) sued FDA on the grounds that FDAs decision to end the tirzepatide shortage was unlawful because, inter alia, FDA failed to provide notice and seek comments from interested stakeholders

Tirzepatide is a dual agonist (GLP-1 + GIP) that is FDA-approved as Mounjaro and Zepbound and commercially available by prescription

This kind of documentation also helps your provider make better dosing decisions based on your response patterns and helps you identify which common mistakes to avoid as you progress through the protocol